We are live on ! Find out more
CMTA

Clementia Pharmaceuticals Inc.
CMTA

Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

38 hedge funds and large institutions have $342M invested in Clementia Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

3% more funds holding

Funds holding: 37 → 38 (+1)

16% less capital invested

Capital invested by funds: $410M → $342M (-$67.3M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
14
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.2M
3
LCM
Laurion Capital Management
New York
+$3.72M
4
AG
Artal Group
Luxembourg
+$3.25M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$11.1M
2
EC
EcoR1 Capital
California
-$3.69M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.32M
4
EAM
Eventide Asset Management
Massachusetts
-$1.14M
5
Norges Bank
Norges Bank
Norway
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$249K +$267K +16,418 New
ARTA
27
A.R.T. Advisors
New York
$232K +$250K +15,374 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$230K – – –
Northern Trust
29
Northern Trust
Illinois
$160K -$3.73K -229 -2%
AAMU
30
Amundi Asset Management US
Massachusetts
$70K – – –
PCM
31
Prelude Capital Management
New York
$56K +$5.43K +334 +10%
TRCT
32
Tower Research Capital (TRC)
New York
$32K +$34.6K +2,124 New
1832 Asset Management
33
1832 Asset Management
Ontario, Canada
$15K +$16.3K +1,000 New
UBS Group
34
UBS Group
Switzerland
$14K +$2.98K +183 +25%
FDCDDQ
35
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7.58K -$8.13K -500 -50%
Bank of America
36
Bank of America
North Carolina
$7K +$7.88K +484 New
FPF
37
FNY Partners Fund
New York
$4K +$4.88K +300 New
RCM
38
RA Capital Management
Massachusetts
– -$11.1M -585,403 Closed
EC
39
EcoR1 Capital
California
– -$3.69M -194,166 Closed
Citadel Advisors
40
Citadel Advisors
Florida
– -$2.32M -122,040 Closed
EAM
41
Eventide Asset Management
Massachusetts
– -$1.14M -60,000 Closed
Norges Bank
42
Norges Bank
Norway
– -$949K -50,000 Closed
Victory Capital Management
43
Victory Capital Management
Texas
– -$659K -34,710 Closed
JGC
44
J. Goldman & Co
New York
– -$488K -25,692 Closed
Millennium Management
45
Millennium Management
New York
– -$196K -10,319 Closed
Deutsche Bank
46
Deutsche Bank
Germany
– -$1K -100 Closed
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
– -$49 -3 -43%
1
2

CMTA Hedge Fund Activity: Q1 2018 in Review

38 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q1 2018, worth a combined $342M — down 16% from $410M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CMTA positions and 9 closed out — a net gain of 1 holder — while 14 added to existing stakes and 6 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $10.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $11.1M sold.

  • 38 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q1 2018, up from 37 in Q4 2017.
  • Funds reported $342M of Clementia Pharmaceuticals Inc. stock for Q1 2018, down 16% quarter-over-quarter.
  • 10 funds opened new Clementia Pharmaceuticals Inc. positions in Q1 2018 and 9 closed out, a net change of +1 holder.
  • The largest Clementia Pharmaceuticals Inc. buyer in Q1 2018 was Janus Henderson Group, an estimated $10.5M added.
  • The largest Clementia Pharmaceuticals Inc. seller in Q1 2018 was RA Capital Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q1 2018.